在捐赠精子治疗中管理遗传疾病的风险:比利时生育诊所的现行做法
Dorian Accoe1, Guido Pennings1, Kelly Tilleman2
1Department of Philosophy and Moral Sciences, Ghent University, Ghent, Belgium.
Reproductive biomedicine online
|August 30, 2024
概括
比利时的生育诊所展示了各种方法来管理在捐赠精子治疗中的遗传风险,尽管普遍存在不良事件. 需要一致的协议来确保安全和知情同意在辅助生殖.
科学领域:
- 生殖医学 生殖医学
- 遗传学 遗传学 是一个
- 公共卫生 公共卫生
背景情况:
- 捐赠精子治疗在辅助生殖中很常见.
- 遗传条件在捐赠者怀孕中存在风险.
- 缺乏标准化的风险管理协议.
研究的目的:
- 调查比利时的生育诊所如何管理捐赠精子治疗中的遗传风险.
- 识别捐赠者查和不良事件管理协议的变化.
主要方法:
- 2023年6月,向比利时所有生育诊所发送电子问卷.
- 分析了来自15家诊所的匿名精子捐赠者治疗 (2018-2022) 数据.
- 方法包括捐赠者风险评估,载体查和不良事件报告.
主要成果:
- 所有诊所都评估了供体风险,83.3%使用了常见的自体衰退性疾病的载体查.
- 尽管进行了查,但报告的每100名儿童中有9.4例不良事件.
- 对不良事件的临床反应,包括捐赠者通知和精子使用,差异很大.
结论:
- 在捐赠精子治疗中普遍存在疑似或检测到的遗传条件.
- 比利时的诊所在预防和管理遗传风险方面表现出很大的差异.
- 需要标准化指导方针,以便在捐赠者受孕中进行一致的风险管理.
相关概念视频
What is Genetic Engineering?
73.9K
Overview
73.9K
Spermatogenesis
102.3K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.3K
Infertility in Males
255
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
255
CRISPR
49.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.9K


